Weekly Oral Risperidone Found Effective and Safe for Schizophrenia in Phase III Trial Dr Riya Dave25 Jun 2025 9:00 PM ISTResearchers have found in a Phase III Trial that patients with schizophrenia who were treated with the investigational long-acting oral weekly...
Multiple Agents Show Promise in Treating Acute Bipolar Depression Dr. Kamal Kant Kohli28 Aug 2023 8:00 PM ISTRecent research published in LANCET Psychiatry has brought to light a significant advancement in the treatment of acute bipolar depression. A study...
Agomelatine safe and effective option for children with major depressive disorder: Lancet Dr. Shravani Dali8 Feb 2022 9:00 AM ISTAgomelatine is safe and efficient in children and adolescents with major depressive disorder according to a recent study published in The Lancet...
Alcohol use disorder can be improved without quitting through behavioural harm-reduction: Lancet Medha Baranwal18 March 2021 6:45 AM ISTUSA: Combined behavioural harm-reduction and pharmacological treatment can reduce alcohol use and alcohol-related harm without having to quit or...
Prescribed cannabidiol could help people quit cannabis: Lancet Psychiatry Dr. Kamal Kant Kohli29 July 2020 9:15 AM ISTA benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.Results...
India needs national suicide prevention strategy, stresses NIMHANS study Medha Baranwal30 Jan 2020 4:26 PM ISTBangalore, India: A comprehensive national suicide prevention strategy for any country, and for India in particular, needs information on both suicide...
Smokers more likely to develop Schizophrenia: Study Meghna A Singhania11 July 2015 11:56 AM ISTActive smoking affects the chemical composition in the brain, and can instigate direct role in the development of schizophrenia. The study also...
